Bristol-Myers Squibb Company News Headlines

BMY 
$65.67
*  
3.75
6.06%
Get BMY Alerts
*Delayed - data as of Mar. 4, 2015  -  Find a broker to begin trading BMY now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Bristol-Myers: FDA Expands Approval Of Opdivo To Treat Lung Cancer
3/4/2015 4:24:00 PM - RTT News


Geron's Q4 Loss Narrows Y/Y, Announces Restructuring Plan - Analyst Blog
3/4/2015 10:50:00 AM - Zacks.com


Rigel (RIGL) Down on Wider Q4 Loss, Revenues Increase Y/Y - Analyst Blog
3/4/2015 9:10:00 AM - Zacks.com


European Stocks Seen Rising; ECB Meeting Eyed
3/4/2015 2:18:00 AM - RTT News


Bristol-Myers To License Bavarian Nordic's Prostvac For Up To $975 Mln
3/4/2015 1:45:00 AM - RTT News


Amgen: The Best Biotech Stock You Don't Own
3/3/2015 5:04:00 PM - Seeking Alpha


Bristol-Myers Files for New Indications for Yervoy, Opdivo - Analyst Blog
3/3/2015 3:13:00 PM - Zacks.com


Bristol-Myers To Present At Cowen And Co. Conference; Webcast At 9:20 AM ET
3/3/2015 8:24:00 AM - RTT News


Bristol-Myers: ALLY-2 Phase 3 Trial Achieves Hepatitis C Cure Rate Of 97%
3/3/2015 6:21:00 AM - RTT News


The Dividend House DGI Portfolio: The Good, The Bad, And The Ugly
3/3/2015 12:51:00 AM - Seeking Alpha


BMY To Face FDA, XON Springs A Surprise, AERI Awaits Rocket To Deliver
3/3/2015 12:23:00 AM - RTT News


Is Now The Time To Pounce On The Pot Business?
3/2/2015 3:09:00 PM - Seeking Alpha


Bristol Myers' HCV Cocktail Has Gilead, AbbVie In Its Crosshairs
3/2/2015 10:32:00 AM - Seeking Alpha


AMGN's Kyprolis Better Than Rival, KOOL Put On Notice, XON Inks Fruity Deal
3/2/2015 1:42:00 AM - RTT News


Some Companies Are More Wonderful Than Others
3/1/2015 5:02:00 AM - Seeking Alpha


Which Cancer Immunotherapy Will Be the Most Successful?
2/28/2015 9:59:02 AM - Motley Fool


Seeking Alpha's Biotech Weekly: Achillion Overdone, Sanofi's Toujeo A Go, And More
2/27/2015 4:00:00 PM - Seeking Alpha


5 Top-Heavy Stocks to Sell: Oracle, Michael Kors and More
2/27/2015 8:26:00 AM - TheStreet


Exchange-traded funds that hold big pharma
2/26/2015 9:05:00 AM - Market Realist


How to arrive at valuations for big pharma
2/25/2015 3:05:00 PM - Market Realist


Flexus Shows Other Immuno-Oncology Wannabes How It's Done
2/25/2015 2:28:00 PM - Seeking Alpha


Bristol-Myers Announces Data From Phase IIb Trial Of BMS-663068
2/25/2015 8:41:00 AM - RTT News


The 3 Biggest Disappointments This Earnings Season
2/25/2015 7:15:02 AM - Motley Fool


Bristol-Myers to Buy Flexus, Team Up with Rigel - Analyst Blog
2/24/2015 6:54:00 PM - Zacks.com


BMY, VRX Open Wallet, LLY Does It Again, RIGL Gets A Regal Touch, TRIB Is Back
2/24/2015 12:48:00 AM - RTT News